HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 287.87 billion as of May 13, 2025. Its market cap has decreased by -32.12% in one year.

Market Cap

287.87B

Enterprise Value

n/a

Revenue

36.10B

Ranking

n/a

PE Ratio

609.04

Stock Price

20,400.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 287.87B, an increase of 241.56%. That is a compound annual growth rate of 13.96%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	287.87B	-14.94%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	70.53T
Celltrion	32.90T
ALTEOGEN	17.91T
Yuhan	8,074.07B
HLB Co., Ltd.	7,463.37B
SK Biopharmaceuticals	6,930.72B
PharmaResearch	4,135.08B
Peptron	3,983.85B

Market Cap Rankings